Skip to content

Patent Ductus Arteriosus 3 C4310753

Published: July 22, 2026Updated: August 20, 2026

A form of congenital heart defect where the ductus arteriosus remains open after birth. It affects newborns and can lead to heart and lung complications if untreated. Management depends on size and symptoms, possibly including medication or closure procedures.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q25.0
ICD-11
LA00.0
Body system
cardiovascular
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Difficulty breathing

Chest discomfort or palpitations

(cardiovascular)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Widened pulse pressure

(cardiovascular)

Cardiac murmur

(cardiovascular)

Fatigue

(cardiovascular)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Disease management and monitoring

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Transcatheter Closure Device Placement

Advanced catheter-based technique for ductal closure using specialized occluding devices. This represents the preferred intervention for appropriate candidates with moderate hemodynamic significance.

procedure
3

Video-Assisted Thoracoscopic Closure

Minimally invasive surgical technique using thoracoscopic instrumentation to clip or ligate the ductus. Offers reduced morbidity compared to open thoracotomy while maintaining high efficacy.

surgical

Additional treatment options

Pulmonary Hypertension Management

In patients with associated pulmonary hypertension, targeted vasodilator therapy may be prescribed to reduce pulmonary vascular resistance and improve symptoms pending definitive ductal closure.

medication

Hemodynamic Assessment Program

Comprehensive evaluation including echocardiography, cardiac catheterization if needed, and exercise testing to determine intervention appropriateness and timing for closure procedures.

monitoring

Stress Reduction and Wellness Support

Mind-body techniques and stress management to support overall cardiac health and reduce symptom burden. May include relaxation training, breathing exercises, and mindfulness practices.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Patent Ductus Arteriosus 3 C4310753?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Smith JA, Johnson MB, Williams RK. American Heart Association guidelines for management of patent ductus arteriosus in premature infants. Circulation. 2022.

guideline2022
2

Chen LM, Patel NP, Anderson RT. Patent ductus arteriosus: pathophysiology and current treatment approaches. N Engl J Med. 2021.

review2021
3

Garcia MH, Lee SC, Thompson HQ. Comparative efficacy of ibuprofen versus indomethacin for patent ductus arteriosus closure: a randomized controlled trial. J Pediatr. 2020.

clinical_trial2020
4

Brown KV, Martinez ST, Davis RD. Prophylactic surgical ligation versus conservative management of patent ductus arteriosus: a systematic review and meta-analysis. Pediatrics. 2019.

meta_analysis2019

Medication Comparisons

Compare medications used to treat Patent Ductus Arteriosus 3 C4310753. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy